60 DEGREES PHARMACEUTICALS, INC.
SXTPWN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Feb 2027
Market Overview
Stock performance and key metrics
SXTPW News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
Tafenoquine
Babesiosis
Tafenoquine 100mg
Chronic Babesiosis
Tafenoquine Oral Tablet
COVID 19 Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Tafenoquine | Phase 2 | Babesiosis | - | - |
Tafenoquine 100mg | Phase 2 | Chronic Babesiosis | - | - |
Tafenoquine Oral Tablet | Phase 2 | COVID 19 Disease | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply